Canada Inspection 82079 - Intas Pharmaceuticals Limited - March 27, 2023

Canada Health Inspection 82079 for Intas Pharmaceuticals Limited on March 27, 2023. Rating: C. Access full inspection details and violations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

Canada Health Inspection 82079 for Intas Pharmaceuticals Limited on March 27, 2023. Rating: C. Access full inspection details and violations.

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Intas Pharmaceuticals Limited

Inspection Date

March 27, 2023

Product Type

drugs

ID: 7514f741-e237-4c00-9ea2-889e5e7d82ac

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox